logo
Detail still lacking ‘but Ireland would be worse off without EU-US deal'

Detail still lacking ‘but Ireland would be worse off without EU-US deal'

Yahooa day ago
A swathe of tariffs imposed on other nations show Ireland would be worse off if there was not an EU-US trade deal, the Irish deputy premier said.
US president Donald Trump signed an executive order that sees tariffs of 15% or above imposed on trading partners including Brazil, Lesotho, Taiwan and Switzerland.
The EU struck a trade deal with the US five days before Mr Trump said a 30% tariff would kick in for the bloc.
The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US.
There are 'zero for zero' tariffs on a number of products including aircraft, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years.
Simon Harris said on Friday after a meeting of the trade forum at Government Buildings that a lot of detail of the agreement still needs to be clarified as he defended the deal.
'Without a deal between the US and the EU, today would have seen 30% tariffs introduced by President Trump on the EU, and would also have seen very, very significant counter measures introduced by the EU to the tune of around 90 odd billion euro,' the Tanaiste said.
'There's absolutely no doubt that that would have been a moment of catastrophe in terms of our economic wellbeing as a country.'
He added: 'We'd be in a very different and a much worse position I think if we were standing here today with no deal.
'You don't have to take my word for that, if you just see the executive order last night and all of the tariffs levelled in other countries, including countries that didn't have deals.
'They were generally much, much higher than the tariff rate for the European Union.'
He said the EU tariff rate of 15% would come into effect from August 7.
Tariffs on pharmaceuticals would remain at zero until the US administration concludes its Section 232 investigation, relating to imported goods of importance to national security, into the sector.
Mr Harris said he was informed by Brussels that this is expected to conclude in around two weeks.
Mr Harris also said 'there is too many variables' to yet know the effect of the tariff differential between Northern Ireland and Ireland.
He said he spoke with Northern Ireland First Minister Michelle O'Neill, deputy First Minister Emma Little-Pengelly, and the Economy Minister Caoimhe Archibald who agreed on this.
'So to give you an example, at the moment butter in Ireland already has a tariff of around 16% on it, pre-existing.
'It's had 10% on top of that since President Trump's last round, so that's meant butter in Ireland had a tariff of 26%. Under the new EU deal, that will fall to 16%.
'Butter in the UK, if I can use that as a comparison, will actually probably end up with 16%, plus 10%, so 26%.
'I'm just using a pound of butter as an example here, but if you look at it, you know, at a headline rate, you'd say 'Well, there'd be lower tariff on butter in the UK than Ireland', and actually that's probably not the case.
'So we need to tease our way through this. But there is no doubt that there will be challenges that will have to be worked through.'
He said: 'I suppose the last point I'd make is that this is a subset of businesses. It's really a subset of a subset, because this will obviously only affect businesses that are doing cross-border trade and exporting to the United States of America. So it's not to be in any way dismissive of that, but it will obviously only affect that proportion of the business community.
'Pharma is another example. I mean, the EU seems to have a commitment in writing to 15% or less, no more than 15% for pharma.
'The UK language is much more vague. It doesn't have a number beside it, so we'll need to see where that brings us in the weeks ahead.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rachel Reeves making ‘even bigger mistakes' than Liz Truss, says Kemi Badenoch
Rachel Reeves making ‘even bigger mistakes' than Liz Truss, says Kemi Badenoch

Yahoo

time7 minutes ago

  • Yahoo

Rachel Reeves making ‘even bigger mistakes' than Liz Truss, says Kemi Badenoch

Kemi Badenoch has said Rachel Reeves is making 'even bigger mistakes' than Liz Truss. The Tory leader hit out at the Chancellor and the Prime Minister for their economic decisions as she drew a critical comparison to her predecessor at the top of the Conservative Party. 'For all their mocking of Liz Truss, Keir Starmer and Rachel Reeves have not learnt the lessons of the mini-budget and are making even bigger mistakes,' Mrs Badenoch wrote in The Telegraph. 'They continue to borrow more and more, unable and unwilling to make the spending cuts needed to balance the books.' Short-lived Conservative prime minister Ms Truss's mini-budget spooked the financial markets in 2022 and led to a spike in mortgage rates. 'As we all saw in 2022, the Chancellor and the Prime Minister are reliant on the bond markets,' Mrs Badenoch added. 'Yet those bond markets are increasingly jittery about the levels of borrowing today with no balancing spending decreases. 'Rachel Reeves's unfunded series of U-turns have only added to the pressure. She is boxed in by her party on one side, and her fiscal rules on the other.' The Chancellor earlier admitted Labour had 'disappointed' people while in Government, but said that the Government had got the balance right between tax, spending and borrowing. She told an audience at the Edinburgh Fringe Festival that balancing the books meant making tough decisions, even if the are unpopular. Appearing on the Iain Dale All Talk Fringe show, she said: 'The reason people voted Labour at the last election is they want to change and they were unhappy with the way that the country was being governed. 'They know that we inherited a mess. They know it's not easy to put it right, but people are impatient for change. 'I'm impatient for change as well, but I've also got the job of making sure the sums always add up – and it doesn't always make you popular because you can't do anything you might want to do. You certainly can't do everything straight away, all at once.' Ms Reeves pointed to Labour's £200 million investment in carbon capture in the north-east of Scotland, which she said was welcomed by the industry. At the same time, Labour's windfall tax, she said, was not liked by the sector. 'I can understand that that's extra tax that the oil and gas sector are paying, but you can't really have one without the other,' she said. Defending Labour's record, she said her party had the 'balance about right'. 'But of course you're going to disappoint people,' she added. 'No-one wants to pay more taxes. 'Everyone wants more money than public spending – and borrowing is not a free option, because you've got to pay for it. 'I think people know those sort of constraints, but no-one really likes them and I'm the one, I guess, that has to sort the sums up.' Ms Reeves said Labour had to deliver on its general election campaign of change, adding that her party did not 'deserve' to win the next election if it does not deliver the change it promised.

NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns
NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns

Yahoo

time7 minutes ago

  • Yahoo

NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock market. When you buy and hold the right company, the returns can make a huge difference to both you and your family. For example, the NeuroScientific Biopharmaceuticals Limited (ASX:NSB) share price is up a whopping 576% in the last 1 year, a handsome return in a single year. Also pleasing for shareholders was the 410% gain in the last three months. The longer term returns have not been as good, with the stock price only 6.4% higher than it was three years ago. We love happy stories like this one. The company should be really proud of that performance! On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the last year NeuroScientific Biopharmaceuticals grew its earnings per share (EPS) by 54%. The share price gain of 576% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago. The fairly generous P/E ratio of 70.06 also points to this optimism. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). This free interactive report on NeuroScientific Biopharmaceuticals' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective We're pleased to report that NeuroScientific Biopharmaceuticals shareholders have received a total shareholder return of 576% over one year. That's better than the annualised return of 1.2% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with NeuroScientific Biopharmaceuticals (including 2 which are potentially serious) . For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cowboys owner Jerry Jones dismisses Micah Parsons' trade request as negotiation talk
Cowboys owner Jerry Jones dismisses Micah Parsons' trade request as negotiation talk

Washington Post

time9 minutes ago

  • Washington Post

Cowboys owner Jerry Jones dismisses Micah Parsons' trade request as negotiation talk

OXNARD, Calif. — Dallas Cowboys owner and general manager Jerry Jones does not intend to trade Micah Parsons after the star defensive end said he wants to leave the team amid a breakdown in negotiating a contract extension. 'Surely you guys have been around this stuff and know how to recognize negotiation talk, that type of thing. And so that's where I put that,' Jones said after practice Saturday, one day after Parsons posted on social media to request a trade .

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store